Maharashtra Herald

One-stop Induced Pluripotent Stem Cells Services are Available at Creative Biolabs

 Breaking News
  • No posts were found

One-stop Induced Pluripotent Stem Cells Services are Available at Creative Biolabs

July 09
23:10 2021
iPSCs have the ability to differentiate into any of the 220+ cell types found in the human body. This capability provides great potential for cell therapies, with a growing range of clinical applications. With years of exploration in iPSC development, Creative Biolabs has established the iPSC technology platform, aiming to provide a complete portfolio of high-quality iPSC research services from genome editing, reprogramming, and characterization to differentiation.

New York, USA – July 9, 2021 – Stem cells are primitive cells that have the ability to transform into any tissues. iPSCs are a type of stem cell that can be induced from adult human cells by reprogramming rather than pre-implantation embryos.

The use of iPSCs in stem cell therapy has immense prospects and offers remarkable applications in regenerative medicine. To date, a number of diseases are currently being treated with stem cells, and clinical trials are being conducted using iPSCs in a similar way. By providing custom iPSC services and producing high-quality iPSCs, Creative Biolabs can reduce the preparation and delivery time for clients’ stem cell projects, giving them more time to focus on research.

Creative Biolabs is able to offer the complete iPSC portfolio to accelerate the success of customer research:

iPSC Reprogramming

iPSCs represent a potential treatment for genetic and degenerative disorders. If possible, patient-derived cells could be cultured and repaired in vitro and then re-administered to the patient. iPSC reprogramming plays an important role in acquiring iPSCs, and its laboratory procedures should comply with rigorous standards.

iPSC Characterization

Characterization of iPSCs is required for the registration of stem cell lines and allows for an impartial and objective comparison of the results obtained when new iPSCs lines are developed.

iPSC Differentiation

Human pluripotent stem cells (hPSCs) can theoretically generate unlimited quantities of any cell lineage in vitro, including neuronal cells, hepatocytes, cardiomyocytes, and they hold great potential for disease modeling, drug screening, and cell-based therapies.

iPSC Genome Editing

CRISPR/Cas9 mediated gene modification combined with human iPSC technology provides a powerful tool for generating disease-specific models for drug discovery researchers.

“iPSCs have opened a new frontier in disease research,” said a scientist at Creative Biolabs. “We are proud to provide customers around the world with these vital services that enable disease and biomedical research, drug/therapeutics discovery and development.”

About Creative Biolabs

As a leading company in the field of biotechnology, Creative Biolabs is recognized for reliable, high-quality service, global capacity, innovative technology platform, and extensive experience. Driven by science and a passion for quality, Creative Biolabs is committed to providing comprehensive, low-cost iPSC support to meet the needs of customers.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/stem-cell-therapy